Protocol Design Featured Articles

  1. 4 Things I Learned At SCOPE 2024 2/21/2024

    The Summit for Clinical Ops Executives (SCOPE) ran from Feb. 11-4. Discover four things Executive Editor Abby Proch learned at the annual event.

  2. How To Improve Your Clinical Finance Function 2/16/2024

    In the finale of this three-part series on clinical finance, IGM Biosciences Vice President, Financial Planning & Analysis Chris Chan discusses how to leverage the role of clinical finance for clinical trial success. 

  3. Ramblings From A First-Time SCOPE Attendee 2/15/2024

    Dan Schell, chief editor of Clinical Leader, discusses what sessions stood out to him and some of the KOLs he rubbed elbows with while attending his first SCOPE Summit. 

  4. Why Is Clinical Finance Important? 2/15/2024

    In part two, IGM Biosciences Vice President, Financial Planning & Analysis Chris Chan explains just how important the role of clinical finance can be in bringing harmony and success into clinical research.

  5. Why Is Clinical Finance So Challenging? 2/14/2024

    IGM Biosciences Vice President, Financial Planning & Analysis Chris Chan explains why the role of clinical finance can be so challenging to define, uphold, and even defend in the world of clinical research.

  6. Making Rare Disease Progress With Novel Strategies, Data Standardization, And More 2/14/2024

    The integration of innovative research methodologies, coupled with the standardization of data and use of advanced visualization techniques, represents a holistic strategy to address the complexities of rare diseases.

  7. Improve Site Selection And Identify Your Ideal Patient With AI Insights 2/1/2024

    As AI sprouts seemingly everywhere across the clinical trial space, the growing alliance between tech and biopharma requires extensive collaboration, ample testing, and greater understanding across the board.

  8. 4 Things I’m Looking Forward To At SCOPE 2024 2/1/2024

    The Summit for Clinical Ops Executives (SCOPE) begins Feb. 11. Discover four things Executive Editor Abby Proch is looking forward to at the annual event.

  9. An Exploration Of ICIs In Cancer Therapy 1/31/2024

    This collection of frequently asked questions highlights the remarkable efficacy of immune checkpoint inhibitors (ICIs) and the projected growth of the global ICI market.

  10. The Impact Of Protocol Design On An IRT System 1/31/2024

    DTP and home treatment studies can get expensive — and be a hassle to patients — if the IRT element isn’t well planned for during trial design. In their SCOPE Summit presentation, Irina Grishina and Kelsey Kern of CSL Behring plan to share their personal anecdotes and lessons learned from both types of trials as they pertain to IRT.